Furosemide and Yupelri drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Furosemide (furosemide) and Yupelri (revefenacin). Common drug interactions include asthenia among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Furosemide and Yupelri. It is created by eHealthMe based on reports of 50 people who take the same drugs from the FDA, and is updated regularly.

What is Furosemide?

Furosemide has active ingredients of furosemide. It is often used in fluid retention. eHealthMe is studying from 316,095 Furosemide users. Check the latest studies of Furosemide.

What is Yupelri?

Yupelri has active ingredients of revefenacin. eHealthMe is studying from 506 Yupelri users. Check the latest studies of Yupelri.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 16, 2026

50 people who take Furosemide and Yupelri together, and have interactions are studied.

Furosemide and Yupelri drug interactions.

What are the common drug interactions of Furosemide and Yupelri, by gender? *:

female:

Asthenia (weakness)
Bone marrow disorder
Catheter site bruise
Chronic left ventricular failure (long lasting functional impairment of left ventricle of heart)
Chronic respiratory failure
Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
Dysphagia (a condition in which swallowing is difficult or painful)
Dysphonia (speech disorder attributable to a disorder of phonation)
Dysuria (painful or difficult urination)
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)

male:

Death
Fall
Cough
Dementia (madness)
Device failure
Drug ineffective
Drug intolerance (drug sensitivity)
Dry mouth
Dry throat
Epistaxis (bleed from the nose)

What are the common drug interactions of Furosemide and Yupelri, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Infusion site pain
Weight decreased

50-59:

n/a

60+:

Death
Dyspnoea (difficult or laboured respiration)
Therapeutic response decreased (less preventive response)
Vision blurred
Lung carcinoma cell type unspecified stage i (the lung cancer is small and hasn't spread to the lymph nodes)
Anaemia (lack of blood)
Angina pectoris (chest pain due to ischemia of the heart muscle)
Asthenia (weakness)
Back pain
Blood pressure decreased

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 19 people, 38.00%
Asthma: 9 people, 18.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 6 people, 12.00%
High Blood Cholesterol: 4 people, 8.00%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 6.00%
Seasonal Allergy (allergic condition due to certain season): 3 people, 6.00%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 6.00%

* Approximation only. Some reports may have incomplete information.

Do you take Furosemide and Yupelri?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously